![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 16083-16091, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Although a number of prostaglandin
E2 (PGE2) receptor subtypes have been
cloned, limited studies have been performed to elucidate subtypes that
subserve specific actions of this eicosanoid, in part because of a
paucity of selective receptor antagonists. Using reverse
transcription-polymerase chain reaction (PCR) and antisense oligonucleotides, we examined which prostaglandin E2
receptor (EP receptor) subtypes are expressed in sensory neurons and
which mediate the PGE2-induced increase in cAMP production
and augmentation of peptide release. Reverse transcription-PCR of
cDNA isolated from rat sensory neurons grown in culture revealed
PCR products for the EP1, EP2, EP3C, and EP4 receptor subtypes but not
the EP3A or EP3B. Preexposing neuronal cultures for 48 h to
antisense oligonucleotides of EP3C and EP4 mRNA diminished
expression of the respective receptors by ~80%, abolished the
PGE2-stimulated production of cAMP, and blocked the ability
of PGE2 to augment release of immunoreactive substance P
and calcitonin gene-related peptide. Pretreating with individual
antisense against the EP2, EP3C, or EP4 receptors or combinations of
missense oligonucleotides had no effect on PGE2-induced
activity. Treatment with antisense to EP3C and EP4 receptor subtypes
did not alter the ability of forskolin to increase cAMP or enhance
peptide release. These results demonstrate that sensory neurons are
capable of expressing multiple EP receptor subtypes but that only the
EP3C and EP4 receptors mediate PGE2-induced sensitization
of sensory neurons.
Prostaglandin Receptor Subtypes, EP3C and EP4, Mediate the
Prostaglandin E2-induced cAMP Production and Sensitization
of Sensory Neurons*
and
§¶
Department of Pharmacology and
Toxicology and ¶ Department of Anesthesia, School of Medicine,
Indiana University, Indianapolis, Indiana 46202-5126
*
This work was supported in part by National Institutes of
Health Grant RO1-NS34159 (to M. R. V.) and by a fellowship from the
American Heart Association, Indiana Affiliate (to M. D. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
S. Jain, G. Chakraborty, R. Raja, S. Kale, and G. C. Kundu Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer Cancer Res., October 1, 2008; 68(19): 7750 - 7759. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schnizler, L. P. Shutov, M. J. Van Kanegan, M. A. Merrill, B. Nichols, G. S. McKnight, S. Strack, J. W. Hell, and Y. M. Usachev Protein Kinase A Anchoring via AKAP150 Is Essential for TRPV1 Modulation by Forskolin and Prostaglandin E2 in Mouse Sensory Neurons J. Neurosci., May 7, 2008; 28(19): 4904 - 4917. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.M. Patwardhan, J. Vela, J. Farugia, K. Vela, and K.M. Hargreaves Trigeminal Nociceptors Express Prostaglandin Receptors J. Dent. Res., March 1, 2008; 87(3): 262 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, Y. Gu, G.-W. Li, and L.-Y. M. Huang A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2-induced potentiation of P2X3 receptor currents in inflamed rats J. Physiol., October 1, 2007; 584(1): 191 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Meisdalen, O. F. Dajani, T. Christoffersen, and D. Sandnes Prostaglandins Enhance Epidermal Growth Factor-Induced DNA Synthesis in Hepatocytes by Stimulation of E Prostanoid 3 and F Prostanoid Receptors J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1044 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakao, A. Murase, H. Ohshiro, T. Okumura, K. Taniguchi, Y. Murata, M. Masuda, T. Kato, Y. Okumura, and J. Takada CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 686 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dogrul, S. E. Gulmez, M. S. Deveci, H. Gul, M. H. Ossipov, F. Porreca, and F. C. Tulunay The Local Antinociceptive Actions of Nonsteroidal Antiinflammatory Drugs in the Mouse Radiant Heat Tail-Flick Test Anesth. Analg., April 1, 2007; 104(4): 927 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, J. D. Ritzenthaler, B. Wingerd, H. N. Rivera, and J. Roman Extracellular Matrix Fibronectin Increases Prostaglandin E2 Receptor Subtype EP4 in Lung Carcinoma Cells through Multiple Signaling Pathways: THE ROLE OF AP-2 J. Biol. Chem., March 16, 2007; 282(11): 7961 - 7972. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Lin, F. Amaya, L. Barrett, H. Wang, J. Takada, T. A. Samad, and C. J. Woolf Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1096 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Payner, H. A. Leaver, B. Knapp, I. R. Whittle, O. C. Trifan, S. Miller, and M. T. Rizzo Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2-dependent activation of type II protein kinase A. Mol. Cancer Ther., July 1, 2006; 5(7): 1817 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schmitz, B. A Levine, and P. W Nathanielsz Localization and steroid regulation of prostaglandin E2 receptor protein expression in ovine cervix. Reproduction, April 1, 2006; 131(4): 743 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Song, Z.-B. Wang, Q. Gan, and E. T. Walters cAMP and cGMP Contribute to Sensory Neuron Hyperexcitability and Hyperalgesia in Rats With Dorsal Root Ganglia Compression J Neurophysiol, January 1, 2006; 95(1): 479 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, J. D. Ritzenthaler, B. Wingerd, and J. Roman Activation of Peroxisome Proliferator-activated Receptor {beta}/{delta} (PPAR{beta}/{delta}) Increases the Expression of Prostaglandin E2 Receptor Subtype EP4: THE ROLES OF PHOSPHATIDYLINOSITOL 3-KINASE AND CCAAT/ENHANCER-BINDING PROTEIN {beta} J. Biol. Chem., September 30, 2005; 280(39): 33240 - 33249. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Tang, R.-S. Yang, and W.-M. Fu Prostaglandin E2 Stimulates Fibronectin Expression through EP1 Receptor, Phospholipase C, Protein Kinase C{alpha}, and c-Src Pathway in Primary Cultured Rat Osteoblasts J. Biol. Chem., June 17, 2005; 280(24): 22907 - 22916. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Kopp, M. Z. Cicha, K. Nakamura, R. M. Nusing, L. A. Smith, and T. Hokfelt Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1269 - F1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, H. Jia, M. Lohr, A. Bagherzadeh, D. I. R. Holmes, D. Selwood, and I. Zachary Anti-chemorepulsive Effects of Vascular Endothelial Growth Factor and Placental Growth Factor-2 in Dorsal Root Ganglion Neurons Are Mediated via Neuropilin-1 and Cyclooxygenase-derived Prostanoid Production J. Biol. Chem., July 16, 2004; 279(29): 30654 - 30661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ghilardi, C. I. Svensson, S. D. Rogers, T. L. Yaksh, and P. W. Mantyh Constitutive Spinal Cyclooxygenase-2 Participates in the Initiation of Tissue Injury-Induced Hyperalgesia J. Neurosci., March 17, 2004; 24(11): 2727 - 2732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Bar, G. Natura, A. Telleria-Diaz, P. Teschner, R. Vogel, E. Vasquez, H.-G. Schaible, and A. Ebersberger Changes in the Effect of Spinal Prostaglandin E2 during Inflammation: Prostaglandin E (EP1-EP4) Receptors in Spinal Nociceptive Processing of Input from the Normal or Inflamed Knee Joint J. Neurosci., January 21, 2004; 24(3): 642 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Mohapatra and C. Nau Desensitization of Capsaicin-activated Currents in the Vanilloid Receptor TRPV1 Is Decreased by the Cyclic AMP-dependent Protein Kinase Pathway J. Biol. Chem., December 12, 2003; 278(50): 50080 - 50090. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Durand, B. Fromy, M. Tartas, A. Jardel, J. L. Saumet, and P. Abraham Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R155 - R161. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hatae, A. Kita, S. Tanaka, Y. Sugimoto, and A. Ichikawa Induction of Adherent Activity in Mastocytoma P-815 Cells by the Cooperation of Two Prostaglandin E2 Receptor Subtypes, EP3 and EP4 J. Biol. Chem., May 9, 2003; 278(20): 17977 - 17981. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Distler, P. K. Rathee, K. S. Lips, O. Obreja, W. Neuhuber, and M. Kress Fast Ca2+-Induced Potentiation of Heat-Activated Ionic Currents Requires cAMP/PKA Signaling and Functional AKAP Anchoring J Neurophysiol, May 1, 2003; 89(5): 2499 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Walch, E. Clavarino, and P. L. Morris Prostaglandin (PG) FP and EP1 Receptors Mediate PGF2{alpha} and PGE2 Regulation of Interleukin-1{beta} Expression in Leydig Cell Progenitors Endocrinology, April 1, 2003; 144(4): 1284 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Gu, K. Kwong, and L.-Y. Lee Ca2+ Transient Evoked by Chemical Stimulation Is Enhanced by PGE2 in Vagal Sensory Neurons: Role of cAMP/PKA Signaling Pathway J Neurophysiol, April 1, 2003; 89(4): 1985 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Southall, T. Li, L. S. Gharibova, Y. Pei, G. D. Nicol, and J. B. Travers Activation of Epidermal Vanilloid Receptor-1 Induces Release of Proinflammatory Mediators in Human Keratinocytes J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dohadwala, R. K. Batra, J. Luo, Y. Lin, K. Krysan, M. Pold, S. Sharma, and S. M. Dubinett Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion J. Biol. Chem., December 20, 2002; 277(52): 50828 - 50833. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kwong and L.-Y. Lee PGE2 sensitizes cultured pulmonary vagal sensory neurons to chemical and electrical stimuli J Appl Physiol, October 1, 2002; 93(4): 1419 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Richardson and M. R. Vasko Cellular Mechanisms of Neurogenic Inflammation J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 839 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Rathee, C. Distler, O. Obreja, W. Neuhuber, G. K. Wang, S.-Y. Wang, C. Nau, and M. Kress PKA/AKAP/VR-1 Module: A Common Link of Gs-Mediated Signaling to Thermal Hyperalgesia J. Neurosci., June 1, 2002; 22(11): 4740 - 4745. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Borgland, M. Connor, R. M. Ryan, H. J. Ball, and M. J. Christie Prostaglandin E2 inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons J. Physiol., March 1, 2002; 539(2): 433 - 444. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |